Overview of the 3rd isirv-Antiviral Group conference - advances in clinical management
More about Open Access at the CrickAuthors list
AC Hurt DS Hui A Hay FG HaydenAbstract
This review highlights the main points which emerged from the presentations and discussions at the 3rd isirv-Antiviral Group Conference - advances in clinical management. The conference covered emerging and potentially pandemic influenza viruses and discussed novel/pre-licensure therapeutics and currently approved antivirals and vaccines for the control of influenza. Current data on approved and novel treatments for non-influenza respiratory viruses such as MERS-CoV, respiratory syncytial virus (RSV) and rhinoviruses and the challenges of treating immunocompromised patients with respiratory infections was highlighted.
Journal details
Volume 9
Issue number 1
Pages 20-31
Publication date
Full text links
Publisher website (DOI) 10.1111/irv.12293
Europe PubMed Central 25399715
Pubmed 25399715
Keywords
Type of publication